H.C. Wainwright: BioMarin’s (BMRN) Amicus Acquisition Stabilizes Cash Flow While Voxzogo Remains Near-Term Driver

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is 1 of the best NASDAQ stocks to bargain successful 2026. On December 22, H.C. Wainwright raised the firm’s terms people connected BioMarin to $60 from $55 with a Neutral standing connected the shares. This sentiment was announced amid the acquisition of Amicus Therapeutics Inc. (NASDAQ:FOLD), which the steadfast described arsenic a determination that stabilizes semipermanent currency flows, though H.C. Wainwright besides noted that highest income won’t materialize until the 2030s. Therefore, Voxzogo volition stay the superior operator of BioMarin’s banal worth successful the interim.

On December 19, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and Amicus Therapeutics announced a definitive statement for BioMarin to get Amicus successful an all-cash transaction valued astatine ~$4.8 billion. Under the presumption of the deal, BioMarin volition wage $14.50 per share. The Boards of Directors of some companies person unanimously approved the merger, which is expected to adjacent successful Q2 2026, pending regulatory clearances and Amicus stockholder approval.

The acquisition strategically expands BioMarin’s enactment successful uncommon diseases by adding 2 high-growth, marketed therapies for lysosomal retention disorders. These see Galafold (migalastat), the archetypal oral attraction for Fabry disease, and Pombiliti + Opfolda, a two-component therapy for Pompe disease. Over the past 4 quarters, these products generated a combined $599 cardinal successful revenue. Additionally, the woody includes US rights to DMX-200, a Phase 3 investigational tiny molecule targeting focal segmental glomerulosclerosis/FSGS, which is simply a uncommon kidney disease.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is simply a biotechnology institution that develops and commercializes therapies for life-threatening uncommon diseases and aesculapian conditions successful the US, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

While we admit the imaginable of BMRN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.